Related Experiment Video
Updated: May 23, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
Protopanaxadiol (PPD)-type ginsenosides inhibit the key element of α-glucosidase - The glycosyl group
Yiming Li1, Yuzhu Shen1, Xianjun Zou1
1School of Food Sciences and Engineering, Changchun University, Changchun 130024, China.
Abstract:
In this study, the inhibitory effects of ten protopanaxadiol (PPD)-type ginsenosides on α-glucosidase in vitro were firstly investigated, and selected four ginsenosides with stronger inhibitory effects, namely CY, C-Mc, F2 and CK. The kinetic results of enzyme inhibition indicated that CY, C-Mc, F2 and CK were all non-competitive inhibitors of α-glucosidase. Fluorescence quenching and circular dichroism (CD) analyses showed that the inhibition of α-glucosidase by CY, C-Mc, F2, and CK was a static process, and that they altered the structure of α-glucosidase. The interaction of the four ginsenosides with α-glucosidase was a spontaneous reaction, mainly driven by hydrogen bonding. At 298 K, the binding constants of CY, C-Mc, F2, and CK with α-glucosidase were 0.70 × 104 mol/L, 0.75 × 104 mol/L, 1.46 × 104 mol/L, 1.65 × 104 mol/L respectively, and the number of binding sites was about 1 for all of them. The molecular docking results showed that CY, C-Mc, F2 and CK bound to sites other than the active center of the α-glucosidase through hydrogen bonds. All the above results showed the structure and hypoglycemic effects of CY, C-Mc, F2 and CK, and they can be used as potential α-glucosidase inhibitors for the treatment of Type 2 diabetes mellitus (T2DM).
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GPCRs Regulate Adenylyl Cylase Activity
Oral Hypoglycemic Agents: Biguanides and Glitazones

